aluates Reports

$ 0.0

Automative

Global CAR-T Cell Immunotherapy Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-10J13802

Global CAR T Cell Immunotherapy Market Research Report 2023

BUY CHAPTERS

Global CAR-T Cell Immunotherapy Market Research Report 2024

Code: QYRE-Auto-10J13802

Report

May 2024

Pages:63

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Kite Pharma

JW Therapeutics

Shanghai Fosun Pharmaceutical Group

CAR-T Cell Immunotherapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

CAR-T Cell Immunotherapy Market

The global CAR-T Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapy.

Report Scope

The CAR-T Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR-T Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR-T Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR-T Cell Immunotherapy Market Report

Report Metric	Details
Report Name	CAR-T Cell Immunotherapy Market
CAGR	5%
Segment by Type	CD19 CD22 Other
Segment by Application	Relapsed or Refractory Mantle Cell Lymphoma (MCL) High Grade B Cell Lymphoma DLBCL Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, Kite Pharma, JW Therapeutics, Shanghai Fosun Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CAR-T Cell Immunotherapy Market report?

Ans: The main players in the CAR-T Cell Immunotherapy Market are Novartis AG, Kite Pharma, JW Therapeutics, Shanghai Fosun Pharmaceutical Group

What are the Application segmentation covered in the CAR-T Cell Immunotherapy Market report?

Ans: The Applications covered in the CAR-T Cell Immunotherapy Market report are Relapsed or Refractory Mantle Cell Lymphoma (MCL), High Grade B Cell Lymphoma, DLBCL, Other

What are the Type segmentation covered in the CAR-T Cell Immunotherapy Market report?

Ans: The Types covered in the CAR-T Cell Immunotherapy Market report are CD19, CD22, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CD19

1.2.3 CD22

1.2.4 Other

1.3 Market by Application

1.3.1 Global CAR-T Cell Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Relapsed or Refractory Mantle Cell Lymphoma (MCL)

1.3.3 High Grade B Cell Lymphoma

1.3.4 DLBCL

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR-T Cell Immunotherapy Market Perspective (2019-2030)

2.2 CAR-T Cell Immunotherapy Growth Trends by Region

2.2.1 Global CAR-T Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CAR-T Cell Immunotherapy Historic Market Size by Region (2019-2024)

2.2.3 CAR-T Cell Immunotherapy Forecasted Market Size by Region (2025-2030)

2.3 CAR-T Cell Immunotherapy Market Dynamics

2.3.1 CAR-T Cell Immunotherapy Industry Trends

2.3.2 CAR-T Cell Immunotherapy Market Drivers

2.3.3 CAR-T Cell Immunotherapy Market Challenges

2.3.4 CAR-T Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR-T Cell Immunotherapy Players by Revenue

3.1.1 Global Top CAR-T Cell Immunotherapy Players by Revenue (2019-2024)

3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Players (2019-2024)

3.2 Global CAR-T Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by CAR-T Cell Immunotherapy Revenue

3.4 Global CAR-T Cell Immunotherapy Market Concentration Ratio

3.4.1 Global CAR-T Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapy Revenue in 2023

3.5 CAR-T Cell Immunotherapy Key Players Head office and Area Served

3.6 Key Players CAR-T Cell Immunotherapy Product Solution and Service

3.7 Date of Enter into CAR-T Cell Immunotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR-T Cell Immunotherapy Breakdown Data by Type

4.1 Global CAR-T Cell Immunotherapy Historic Market Size by Type (2019-2024)

4.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2025-2030)

5 CAR-T Cell Immunotherapy Breakdown Data by Application

5.1 Global CAR-T Cell Immunotherapy Historic Market Size by Application (2019-2024)

5.2 Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CAR-T Cell Immunotherapy Market Size (2019-2030)

6.2 North America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America CAR-T Cell Immunotherapy Market Size by Country (2019-2024)

6.4 North America CAR-T Cell Immunotherapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR-T Cell Immunotherapy Market Size (2019-2030)

7.2 Europe CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe CAR-T Cell Immunotherapy Market Size by Country (2019-2024)

7.4 Europe CAR-T Cell Immunotherapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR-T Cell Immunotherapy Market Size (2019-2030)

8.2 Asia-Pacific CAR-T Cell Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2019-2024)

8.4 Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR-T Cell Immunotherapy Market Size (2019-2030)

9.2 Latin America CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America CAR-T Cell Immunotherapy Market Size by Country (2019-2024)

9.4 Latin America CAR-T Cell Immunotherapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR-T Cell Immunotherapy Market Size (2019-2030)

10.2 Middle East & Africa CAR-T Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2019-2024)

10.4 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Detail

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG CAR-T Cell Immunotherapy Introduction

11.1.4 Novartis AG Revenue in CAR-T Cell Immunotherapy Business (2019-2024)

11.1.5 Novartis AG Recent Development

11.2 Kite Pharma

11.2.1 Kite Pharma Company Detail

11.2.2 Kite Pharma Business Overview

11.2.3 Kite Pharma CAR-T Cell Immunotherapy Introduction

11.2.4 Kite Pharma Revenue in CAR-T Cell Immunotherapy Business (2019-2024)

11.2.5 Kite Pharma Recent Development

11.3 JW Therapeutics

11.3.1 JW Therapeutics Company Detail

11.3.2 JW Therapeutics Business Overview

11.3.3 JW Therapeutics CAR-T Cell Immunotherapy Introduction

11.3.4 JW Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2019-2024)

11.3.5 JW Therapeutics Recent Development

11.4 Shanghai Fosun Pharmaceutical Group

11.4.1 Shanghai Fosun Pharmaceutical Group Company Detail

11.4.2 Shanghai Fosun Pharmaceutical Group Business Overview

11.4.3 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Introduction

11.4.4 Shanghai Fosun Pharmaceutical Group Revenue in CAR-T Cell Immunotherapy Business (2019-2024)

11.4.5 Shanghai Fosun Pharmaceutical Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Novartis

Kite Pharma

JW Therapeutics

Shanghai Fosun Pharmaceutical Group

List of Tables

Table 1. Global CAR-T Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CD19

Table 3. Key Players of CD22

Table 4. Key Players of Other

Table 5. Global CAR-T Cell Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global CAR-T Cell Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global CAR-T Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global CAR-T Cell Immunotherapy Market Share by Region (2019-2024)

Table 9. Global CAR-T Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global CAR-T Cell Immunotherapy Market Share by Region (2025-2030)

Table 11. CAR-T Cell Immunotherapy Market Trends

Table 12. CAR-T Cell Immunotherapy Market Drivers

Table 13. CAR-T Cell Immunotherapy Market Challenges

Table 14. CAR-T Cell Immunotherapy Market Restraints

Table 15. Global CAR-T Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global CAR-T Cell Immunotherapy Market Share by Players (2019-2024)

Table 17. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2023)

Table 18. Ranking of Global Top CAR-T Cell Immunotherapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players CAR-T Cell Immunotherapy Product Solution and Service

Table 22. Date of Enter into CAR-T Cell Immunotherapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global CAR-T Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2019-2024)

Table 26. Global CAR-T Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global CAR-T Cell Immunotherapy Revenue Market Share by Type (2025-2030)

Table 28. Global CAR-T Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2019-2024)

Table 30. Global CAR-T Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global CAR-T Cell Immunotherapy Revenue Market Share by Application (2025-2030)

Table 32. North America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific CAR-T Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific CAR-T Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis AG Company Detail

Table 48. Novartis AG Business Overview

Table 49. Novartis AG CAR-T Cell Immunotherapy Product

Table 50. Novartis AG Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 51. Novartis AG Recent Development

Table 52. Kite Pharma Company Detail

Table 53. Kite Pharma Business Overview

Table 54. Kite Pharma CAR-T Cell Immunotherapy Product

Table 55. Kite Pharma Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 56. Kite Pharma Recent Development

Table 57. JW Therapeutics Company Detail

Table 58. JW Therapeutics Business Overview

Table 59. JW Therapeutics CAR-T Cell Immunotherapy Product

Table 60. JW Therapeutics Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 61. JW Therapeutics Recent Development

Table 62. Shanghai Fosun Pharmaceutical Group Company Detail

Table 63. Shanghai Fosun Pharmaceutical Group Business Overview

Table 64. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product

Table 65. Shanghai Fosun Pharmaceutical Group Revenue in CAR-T Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 66. Shanghai Fosun Pharmaceutical Group Recent Development

Table 67. Research Programs/Design for This Report

Table 68. Key Data Information from Secondary Sources

Table 69. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CAR-T Cell Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global CAR-T Cell Immunotherapy Market Share by Type: 2023 VS 2030

Figure 3. CD19 Features

Figure 4. CD22 Features

Figure 5. Other Features

Figure 6. Global CAR-T Cell Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global CAR-T Cell Immunotherapy Market Share by Application: 2023 VS 2030

Figure 8. Relapsed or Refractory Mantle Cell Lymphoma (MCL) Case Studies

Figure 9. High Grade B Cell Lymphoma Case Studies

Figure 10. DLBCL Case Studies

Figure 11. Other Case Studies

Figure 12. CAR-T Cell Immunotherapy Report Years Considered

Figure 13. Global CAR-T Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global CAR-T Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global CAR-T Cell Immunotherapy Market Share by Region: 2023 VS 2030

Figure 16. Global CAR-T Cell Immunotherapy Market Share by Players in 2023

Figure 17. Global Top CAR-T Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapy as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapy Revenue in 2023

Figure 19. North America CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America CAR-T Cell Immunotherapy Market Share by Country (2019-2030)

Figure 21. United States CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe CAR-T Cell Immunotherapy Market Share by Country (2019-2030)

Figure 25. Germany CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific CAR-T Cell Immunotherapy Market Share by Region (2019-2030)

Figure 33. China CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America CAR-T Cell Immunotherapy Market Share by Country (2019-2030)

Figure 41. Mexico CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa CAR-T Cell Immunotherapy Market Share by Country (2019-2030)

Figure 45. Turkey CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia CAR-T Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Novartis AG Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)

Figure 48. Kite Pharma Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)

Figure 49. JW Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)

Figure 50. Shanghai Fosun Pharmaceutical Group Revenue Growth Rate in CAR-T Cell Immunotherapy Business (2019-2024)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Tumor Diagnosis Solutions Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21H12722

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global Platinum-based Antineoplastic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39F12501

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global Cancer Pain Management Solutions Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27G5590

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Cancer Biological Toxins Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-30Y9507

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions